Nasopharyngeal carcinoma: a review of cases treated by radiotherapy and chemotherapy

Clin Radiol. 1987 Jan;38(1):17-20. doi: 10.1016/s0009-9260(87)80387-2.

Abstract

Between 1965 and 1983, 52 cases of carcinoma of the nasopharynx were treated with radiotherapy alone and 14 treated with combination chemotherapy containing cisplatin followed by a radical course of radiation. Before 1981 all cases were treated by radiotherapy alone with a variety of dose and fractionation regimes. The actuarial overall 3 year survival for these cases was 35%. Twelve of the 14 (86%) who received chemotherapy responded, and in two there was complete disappearance of disease before the radiotherapy. The 3 year survival for those receiving chemotherapy and radiotherapy was 86%. The possible reasons for this apparent improvement are discussed.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / radiotherapy*
  • Child
  • Child, Preschool
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Female
  • Fluorouracil / administration & dosage
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Nasopharyngeal Neoplasms / drug therapy
  • Nasopharyngeal Neoplasms / mortality
  • Nasopharyngeal Neoplasms / radiotherapy*

Substances

  • Bleomycin
  • Cisplatin
  • Fluorouracil